SD Bioline malaria antigen Pf (HRP-2/pLHD) for assessing efficacy of artemisinin combination therapy against Plasmodium falciparum in pediatric patients in the Democratic Republic of the Congo

INTRODUCTION: The emergence of Plasmodium falciparum resistance to artemisinin combination therapy (ACT) is a worrying development. It calls for close surveillance to monitor the efficacy of the drugs. The objectives of this study were to determine the performance of SD Bioline malaria AgPf(HRP-2/pL...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilauzi, Albert Lukuka, Mulumba, Jose Gaby Tshikuka, Magafu, Mgaywa Gilbert Mjungu Damas, Matchaba-Hove, Reginald, Tapera, Roy, Magafu, Naoko Shimizu, Tamfum, Jean Jacques Muyembe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769055/
https://www.ncbi.nlm.nih.gov/pubmed/26966500
http://dx.doi.org/10.11604/pamj.2015.22.304.6348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769055/
https://www.ncbi.nlm.nih.gov/pubmed/26966500
http://dx.doi.org/10.11604/pamj.2015.22.304.6348

Ejemplares similares